Matildo, Jasmine Claire A.
HRN: 23-50-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/18/2023
CO-AMOXICLAV 625MG (TAB)
11/18/2023
11/25/2023
PO
1 Tab
BID
SP NSDV W RMLE And Repair
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes